NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Year-over-year dividends per share growth
Percentile
P31
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -25.78% |
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -50.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | -82.14% |
| Q3 2023 | 0.00% |
| Q2 2023 | -100.00% |
| Q1 2023 | 66.67% |
| Q4 2022 | -78.57% |
| Q3 2022 | 0.00% |
| Q2 2022 | -100.00% |
| Q1 2022 | 300.00% |
| Q4 2021 | -75.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | -100.00% |
| Q1 2021 | -66.67% |
| Q4 2020 | 42.58% |
| Q3 2020 | -0.02% |
| Q2 2020 | -0.14% |
| Q1 2020 | 0.09% |
| Q4 2019 | 68.45% |
| Q3 2019 | -17.68% |
| Q2 2019 | 0.71% |
| Q1 2019 | 0.60% |
| Q4 2018 | -0.08% |
| Q3 2018 | -38.83% |
| Q2 2018 | 0.01% |
| Q1 2018 | -4.00% |
| Q4 2017 | 104.34% |
| Q3 2017 | -40.22% |
| Q2 2017 | 3.91% |
| Q1 2017 | -0.14% |
| Q4 2016 | 168.68% |
| Q3 2016 | 100.86% |
| Q2 2016 | 3.19% |
| Q1 2016 | -3.17% |